Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Platelet-rich plasma and microneedling could potentially help hair regrowth in alopecia areata patients, but more research is needed.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Oxidative stress is important in causing alopecia areata.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

PRP may help hair growth in alopecia areata without major side effects, but more research is needed.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

PRP more effective than minoxidil 5% for treating alopecia areata.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.